Fig. 1

Mechanisms of PD-1/PD-L1 blockade in human cancer. The main mechanisms by which PD-1 blockade mediates anti-tumor effect, either reinvigoration of tumor-specific T cells in the microenvironment or promoting continuous priming of neoantigens, are balanced by modifying factors: age, mutational burden, immune status, and tumor evasion pathways